Cyclacel Pharmaceuticals
CYCC
trading on NASDAQ
since 2006
$8.74
(Δ -29.14%)
-$3.59 since open
Cyclacel Pharmaceuticals is a biopharmaceutical company focused on developing innovative oncology treatments for various cancers, including targeted therapies and other advanced approaches to address unmet medical needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $9.53 | $10.28 | $8.37 | $5.32M | 2.88M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| +$0.00 | n/a | n/a | -Inf% | -Inf% | 0% |